About
InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular access for hemodialysis. The Company's first technology is an arteriovenous graft (AVG) modification that incorporates two cannulation Pods, with low bleed technology, that are resistant to posterior and sidewall needle penetration and injury. The InnAVasc arteriovenous graft was designed to reduce the potential for adverse events and device failures associated with repeated vascular access.
Technologies
Outlook
Mobile Friendly
Typekit
Vimeo
Google Tag Manager
Render
Remote
AI
Keywords
hemodialysis access
immediate access
dialysis needle protection
home hemodialysis
medical equipment manufacturing
hemodialysis safety device
healthcare equipment & supplies
medical innovation
cannulation zones
hemodialysis technology
backplate technology
medical devices
investigational device
medical equipment and supplies manufacturing
protective backplates
needle injury prevention
cannulation confidence
clinical trial
bleeding reduction device
clinical investigation device
raised target zones
investigational vascular graft
b2b
dialysis access
medical research
dialysis safety
needle puncture protection
vascular access improvement
vascular access device
self-sealing materials
Company Information
-
Employees 1
-
Founded 2013
-
Annual Revenue $12000000
-
Total Funding $4582672
Location
110 Swift Ave, Durham, North Carolina, United States, 27705-4800
